Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul;27(3):324-337.
doi: 10.4037/aacnacc2016703.

Clostridium difficile Infection and Fecal Microbiota Transplant

Alyssa Liubakka  1 , Byron P Vaughn  1
Affiliations
Review

Clostridium difficile Infection and Fecal Microbiota Transplant

Alyssa Liubakka et al. AACN Adv Crit Care. 2016 Jul.

Abstract

Clostridium difficile infection (CDI) is a major source of morbidity and mortality for hospitalized patients. Although most patients have a clinical response to existing antimicrobial therapies, recurrent infection develops in up to 30% of patients. Fecal microbiota transplant is a novel approach to this complex problem, with an efficacy rate of nearly 90% in the setting of multiple recurrent CDI. This review covers the current epidemiology of CDI (including toxigenic and nontoxigenic strains, risk factors for infection, and recurrent infection), methods of diagnosis, existing first-line therapies in CDI, the role of fecal microbiota transplant for multiple recurrent CDIs, and the potential use of fecal microbial transplant for patients with severe or refractory infection.

Keywords: Clostridium difficile infection; fecal microbiota transplant; fecal transplant; recurrent C difficile infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure
Figure
Proposed clinical algorithm for the management of recurrent Clostridium difficile infection (CDI). Note that the specific choice of antibiotics may vary. The most common prolonged antibiotic course would be a 6-week oral vancomycin taper; however, other prolonged courses may be acceptable as well. Before fecal microbiota transplant (FMT), the patient should be treated with antibiotics for at least 10 to 14 days to control the infection. *Although guidelines suggest that the same antibiotics can be used for the first recurrence, we recommend using vancomycin or fidaxomicin.
See this image and copyright information in PMC

References

    1. Hall IC, O'Toole E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child. 1935;49(2):390–402.
    1. al Saif N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol. 1996;45(2):133–137. - PubMed
    1. Rao A, Jump RL, Pultz NJ, Pultz MJ, Donskey CJ. In vitro killing of nosocomial pathogens by acid and acidified nitrite. Antimicrob Agents Chemother. 2006;50(11):3901–3904. - PMC - PubMed
    1. Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect. 2007;13:457–459. - PubMed
    1. Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) MMWR Recomm Rep. 2003;52(Rr-10):1–42. - PubMed